Richardson Financial Services Inc. Sells 226 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Richardson Financial Services Inc. trimmed its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 8.7% during the second quarter, HoldingsChannel.com reports. The firm owned 2,379 shares of the healthcare conglomerate’s stock after selling 226 shares during the quarter. UnitedHealth Group makes up 0.9% of Richardson Financial Services Inc.’s portfolio, making the stock its 23rd largest position. Richardson Financial Services Inc.’s holdings in UnitedHealth Group were worth $1,212,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in UNH. Aveo Capital Partners LLC grew its position in UnitedHealth Group by 23.8% during the fourth quarter. Aveo Capital Partners LLC now owns 2,164 shares of the healthcare conglomerate’s stock worth $1,139,000 after buying an additional 416 shares in the last quarter. 9258 Wealth Management LLC raised its stake in UnitedHealth Group by 7.3% in the fourth quarter. 9258 Wealth Management LLC now owns 4,273 shares of the healthcare conglomerate’s stock valued at $2,250,000 after purchasing an additional 290 shares in the last quarter. Gryphon Financial Partners LLC grew its stake in UnitedHealth Group by 80.9% in the 4th quarter. Gryphon Financial Partners LLC now owns 6,220 shares of the healthcare conglomerate’s stock worth $3,275,000 after buying an additional 2,782 shares in the last quarter. TrinityPoint Wealth LLC raised its position in shares of UnitedHealth Group by 102.8% during the 4th quarter. TrinityPoint Wealth LLC now owns 14,774 shares of the healthcare conglomerate’s stock valued at $7,778,000 after buying an additional 7,489 shares in the last quarter. Finally, Quest Partners LLC purchased a new position in UnitedHealth Group in the fourth quarter worth $668,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 0.4 %

Shares of UnitedHealth Group stock opened at $580.32 on Thursday. The company’s fifty day simple moving average is $574.38 and its two-hundred day simple moving average is $519.42. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $607.94. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67. The company has a market cap of $535.88 billion, a P/E ratio of 35.47, a PEG ratio of 1.64 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, topping the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business had revenue of $98.86 billion during the quarter, compared to analyst estimates of $98.73 billion. During the same period last year, the business posted $6.14 earnings per share. UnitedHealth Group’s quarterly revenue was up 6.4% compared to the same quarter last year. Research analysts anticipate that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.45%. The ex-dividend date is Monday, September 16th. UnitedHealth Group’s dividend payout ratio is presently 51.34%.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on UNH. Baird R W upgraded UnitedHealth Group to a “strong-buy” rating in a report on Thursday, May 30th. JPMorgan Chase & Co. increased their price target on shares of UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a research report on Thursday, May 30th. TD Cowen boosted their price objective on shares of UnitedHealth Group from $546.00 to $601.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. Robert W. Baird lifted their target price on shares of UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 17th. Finally, Barclays raised their price objective on UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. One analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group has an average rating of “Buy” and a consensus target price of $614.17.

Insider Activity at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at $16,812,029.88. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by corporate insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.